Björn Stollenwerk

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

Adrianus J. de Langen, Melissa L. Johnson, Julien Mazières et al. · The Lancet · 2023 · 507 citations · Full text

Non-small-cell Lung Cancer, Medicine, Pathology +8

Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany

Markus Lüngen, Björn Stollenwerk, Philipp Messner et al. · International Journal for Equity in Health · 2008 · 179 citations · Full text

Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation

Matthias Hünger, Carla Sabariego, Björn Stollenwerk et al. · Quality of Life Research · 2011 · 117 citations

Cognitive Rehabilitation, Stroke Rehabilitation, Medicine +10

Effects of a nurse-based case management compared to usual care among aged patients with myocardial infarction: results from the randomized controlled KORINNA study

Christa Meisinger, Björn Stollenwerk, Inge Kirchberger et al. · BMC Geriatrics · 2013 · 52 citations · Full text

Economic evaluation of genetic screening for Lynch syndrome in Germany

Franziska Severin, Björn Stollenwerk, Elke Holinski‐Feder et al. · Genetics in Medicine · 2015 · 44 citations

Genetic Testing, Genetic Disorder, Genetic Epidemiology +6